Ethris

Ethris is a technical innovator in the emerging field of messenger RNA therapeutics.

Launch date

2009

Employees

Market cap

Enterprise valuation

€120m (Public information from Dec 2022)

Company register number HRB 182200 (München)

Planegg Bavaria (HQ)

http://ethris.com/

https://twitter.com/ethris_mrna https://www.linkedin.com/company/ethris-gmbh

Revenues, earnings & profits over time

EUR	2015	2016	2017	2018	2019	2020	2021
Profit	(3.9m)	(5.7m)	(3.2m)	(<1m)	(2.2m)	3.8m	<1m

Date	Investors	Amount	Round
-	OrbiMed	N/A	-
Jan 2009	Ludwig Maximilian University of Munich	N/A	Spinout
Dec 2011	N/A	N/A	Series A
May 2019	Eurostars SME programme	N/A	Grant
Feb 2022*	Laureus Capital	$26.3m	Series B
Dec 2022*	Cipla	$16.0m Valuation: $132m	Late VC
Total Funding		€38.4m

Tech stackLearn more about the technologies and tools that this company uses.